Surgery of skeletal metastases.

Standard

Surgery of skeletal metastases. / Katzer, Alexander; Meenen, Norbert; Grabbe, Frederike; Rueger, Johannes Maria.

In: ARCH ORTHOP TRAUM SU, Vol. 122, No. 5, 5, 2002, p. 251-258.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Katzer, A, Meenen, N, Grabbe, F & Rueger, JM 2002, 'Surgery of skeletal metastases.', ARCH ORTHOP TRAUM SU, vol. 122, no. 5, 5, pp. 251-258. <http://www.ncbi.nlm.nih.gov/pubmed/12070642?dopt=Citation>

APA

Katzer, A., Meenen, N., Grabbe, F., & Rueger, J. M. (2002). Surgery of skeletal metastases. ARCH ORTHOP TRAUM SU, 122(5), 251-258. [5]. http://www.ncbi.nlm.nih.gov/pubmed/12070642?dopt=Citation

Vancouver

Katzer A, Meenen N, Grabbe F, Rueger JM. Surgery of skeletal metastases. ARCH ORTHOP TRAUM SU. 2002;122(5):251-258. 5.

Bibtex

@article{9f46d76513534dcbb2fa7709cec7a54e,
title = "Surgery of skeletal metastases.",
abstract = "During a period of 5 years, 74 female and 27 male patients with an average age of 63.3 years underwent a total of 117 operations for the management of impending ( n=41) or already existing ( n=76) pathologic fractures due to osseous metastases. The average stay in hospital was 17.8 days, and the average postoperative survival 15.8 months. The patients whose limbs were stabilized as a preventive measure were discharged 1.5 days earlier and survived surgery 5.9 months longer than the patients with pathologic fractures. The large percentage of female patients is due to the predominant role of mammary cancer (50%) and the comparatively long survival of patients after a primary diagnosis of this type of carcinoma. The other diagnoses involved were (in order of frequency): bronchial carcinoma (11%), hypernephroma (8%) and non-Hodgkin's lymphoma (8%). The metastases were mainly located at the proximal end or shaft of the femur (59.8%) and in the humerus (18.8%) so that in the majority of cases it was possible to implant weight-bearing prostheses or at least achieve enough stability to allow non-weight-bearing physiotherapy and thus early remobilization. The rate of systemic complications (excluding fatalities) was 14.5%. Local complications in the operated area occurred in 24.8% of cases. As a result, revision surgery was necessary in 10 cases (8.5%), and the fatality rate in hospital (6 weeks) was 7.9%. In view of the advanced stage of the disease in most of the patients, some of them with polypathia, we see these results as a basis for the generous indication for preventive stabilization of osseous metastases. Except in some cases, the primary intention of this therapy is not to cure the disease or prolong life but to improve the quality of life remaining for these patients while keeping their stay in hospital as short as possible and the rate of complications at an acceptable level.",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, Survival Rate, Postoperative Complications, Bone Neoplasms/complications/mortality/*secondary/*surgery, Fractures, Spontaneous/etiology/surgery, Adult, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, Survival Rate, Postoperative Complications, Bone Neoplasms/complications/mortality/*secondary/*surgery, Fractures, Spontaneous/etiology/surgery",
author = "Alexander Katzer and Norbert Meenen and Frederike Grabbe and Rueger, {Johannes Maria}",
year = "2002",
language = "English",
volume = "122",
pages = "251--258",
journal = "ARCH ORTHOP TRAUM SU",
issn = "0936-8051",
publisher = "Springer",
number = "5",

}

RIS

TY - JOUR

T1 - Surgery of skeletal metastases.

AU - Katzer, Alexander

AU - Meenen, Norbert

AU - Grabbe, Frederike

AU - Rueger, Johannes Maria

PY - 2002

Y1 - 2002

N2 - During a period of 5 years, 74 female and 27 male patients with an average age of 63.3 years underwent a total of 117 operations for the management of impending ( n=41) or already existing ( n=76) pathologic fractures due to osseous metastases. The average stay in hospital was 17.8 days, and the average postoperative survival 15.8 months. The patients whose limbs were stabilized as a preventive measure were discharged 1.5 days earlier and survived surgery 5.9 months longer than the patients with pathologic fractures. The large percentage of female patients is due to the predominant role of mammary cancer (50%) and the comparatively long survival of patients after a primary diagnosis of this type of carcinoma. The other diagnoses involved were (in order of frequency): bronchial carcinoma (11%), hypernephroma (8%) and non-Hodgkin's lymphoma (8%). The metastases were mainly located at the proximal end or shaft of the femur (59.8%) and in the humerus (18.8%) so that in the majority of cases it was possible to implant weight-bearing prostheses or at least achieve enough stability to allow non-weight-bearing physiotherapy and thus early remobilization. The rate of systemic complications (excluding fatalities) was 14.5%. Local complications in the operated area occurred in 24.8% of cases. As a result, revision surgery was necessary in 10 cases (8.5%), and the fatality rate in hospital (6 weeks) was 7.9%. In view of the advanced stage of the disease in most of the patients, some of them with polypathia, we see these results as a basis for the generous indication for preventive stabilization of osseous metastases. Except in some cases, the primary intention of this therapy is not to cure the disease or prolong life but to improve the quality of life remaining for these patients while keeping their stay in hospital as short as possible and the rate of complications at an acceptable level.

AB - During a period of 5 years, 74 female and 27 male patients with an average age of 63.3 years underwent a total of 117 operations for the management of impending ( n=41) or already existing ( n=76) pathologic fractures due to osseous metastases. The average stay in hospital was 17.8 days, and the average postoperative survival 15.8 months. The patients whose limbs were stabilized as a preventive measure were discharged 1.5 days earlier and survived surgery 5.9 months longer than the patients with pathologic fractures. The large percentage of female patients is due to the predominant role of mammary cancer (50%) and the comparatively long survival of patients after a primary diagnosis of this type of carcinoma. The other diagnoses involved were (in order of frequency): bronchial carcinoma (11%), hypernephroma (8%) and non-Hodgkin's lymphoma (8%). The metastases were mainly located at the proximal end or shaft of the femur (59.8%) and in the humerus (18.8%) so that in the majority of cases it was possible to implant weight-bearing prostheses or at least achieve enough stability to allow non-weight-bearing physiotherapy and thus early remobilization. The rate of systemic complications (excluding fatalities) was 14.5%. Local complications in the operated area occurred in 24.8% of cases. As a result, revision surgery was necessary in 10 cases (8.5%), and the fatality rate in hospital (6 weeks) was 7.9%. In view of the advanced stage of the disease in most of the patients, some of them with polypathia, we see these results as a basis for the generous indication for preventive stabilization of osseous metastases. Except in some cases, the primary intention of this therapy is not to cure the disease or prolong life but to improve the quality of life remaining for these patients while keeping their stay in hospital as short as possible and the rate of complications at an acceptable level.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Survival Rate

KW - Postoperative Complications

KW - Bone Neoplasms/complications/mortality/secondary/surgery

KW - Fractures, Spontaneous/etiology/surgery

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Survival Rate

KW - Postoperative Complications

KW - Bone Neoplasms/complications/mortality/secondary/surgery

KW - Fractures, Spontaneous/etiology/surgery

M3 - SCORING: Journal article

VL - 122

SP - 251

EP - 258

JO - ARCH ORTHOP TRAUM SU

JF - ARCH ORTHOP TRAUM SU

SN - 0936-8051

IS - 5

M1 - 5

ER -